Pituitary Cancer Treatment Market: Introduction

  • Pituitary cancer is a rare form of cancer and only a few hundred cases are recorded globally. This disease is identified in elderly population and 75% of the pituitary cancer cases are diagnosed after the death of the individual. As per the American Brain Tumor Association, benign tumor accounted for 30% to 40% of the total pituitary tumor cases. This tumor is mostly diagnosed in women and men aged between 40 years and 50 years. One from every four people is estimated to suffer from benign pituitary tumor (adenoma), which is non-cancerous. Most pituitary tumors are benign and treatable. Pituitary tumors account for 12% to 19% of the total primary brain tumors.
  • Pituitary cancer is difficult to diagnose, which has driven the development of better and efficient diagnosis. For instance, MRI or CT scans and blood and urine tests are effective in detecting tumors in the pituitary gland. However, the cancerous pituitary tumor is difficult to diagnose until its spreads to another body part. Pituitary cancer spreads in areas inside and outside the brain known as the metastatic pituitary cancer. Common locations are spinal cord, brain blood vessels, nearby bone, lymph nodes, and organs, such as lungs, heart, pancreas, liver, etc.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Key Drivers and Restraints of Global Pituitary Cancer Treatment Market 

  • Increase in ongoing clinical trials for developing treatment for pituitary cancer or pituitary adenomas is a major factor boosting the pituitary cancer treatment market globally. Huge investments being made in neurological disease research and development are likely to propel the global pituitary cancer treatment market. Thus, faster adoption and availability of diagnostic tests across the globe are anticipated to augment the pituitary cancer treatment market. Moreover, medications are also preferred widely for the treatment of pituitary tumors in some cases. Few medications are also provided after the surgery or the radiation therapy. This is estimated to drive the global pituitary cancer treatment market.
  •  Diagnostic techniques are advanced in developed economies, such as the U.S. and Europe as compared to developing economies. However, rise in awareness about various diagnostic tests for pituitary cancer treatment is expected for propel faster adoption in emerging economies of Asia and Latin America. Diagnostics tests identify benign tumors, as they are the largest type of pituitary cancer. Moreover, expertise in radiation therapy and surgeries are likely to create a treatment of the pituitary cancer effective. Surgeries have remained the most preferable primary treatment for any kind of brain tumor, such as pituitary tumors. Furthermore, radiation therapy is gaining popularity across the globe for pituitary tumors regarding non-invasive novel treatment due to technological advancements.

North America to Lead Global Pituitary Cancer Treatment Market

  • In terms of region, the global pituitary cancer treatment market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is considered to be the largest market for pituitary cancer treatment with rising incidences of pituitary cancer, including benign and malignant in the region. Although pituitary cancer is rare, but its diagnosis is difficult. Thus, advanced diagnostic tests and health care infrastructure is likely to boost the pituitary cancer treatment market in North America. Thus, proper diagnosis plays an important role in mitigation of the disease rate. Moreover, expansion of the pituitary cancer patient pool is projected to drive the need for treatment. These factors are fueling the demand for surgeries, radiation therapy, chemotherapy, and development of novel medications for pituitary cancer treatment. As per statistics published by the American Cancer Society in April 2019, around 15,690 pituitary gland tumors are estimated to be diagnosed in the United States. Robust research & development and awareness about pituitary cancer are likely to boost the pituitary cancer treatment market growth in the region.
  • Europe is another region with growing incidences of pituitary cancer. Asia Pacific is the fastest emerging market for pituitary cancer treatment with rise in patient pool. Awareness, adoption of diagnostic tests, and developing health care infrastructure are factors responsible for the market growth in Asia Pacific. Government policies and developing healthcare industry are likely to augment market growth in the region.

Stuck in a neck-to-neck competition with other brands? Request a custom report

Key Manufacturers Operating in Global Pituitary Cancer Treatment Market 

The global pituitary cancer treatment market is highly consolidated. Key manufacturers operating in the global market are:

  • Accuray Incorporated,
  • C. R. Bard, Inc.,
  • Elekta AB 
  • Genentech, Inc (Roche Group)
  • IBA Worldwide
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Nordion Inc.
  • Sigma-Aldrich Co. LLC

Global Pituitary Cancer Treatment Market: Research Scope

Global Pituitary Cancer Treatment Market, by Type

  • Benign  Tumors
  • Malignant Tumors

Global Pituitary Cancer Treatment Market, by Treatment

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Hormonal Medications

Global Pituitary Cancer Treatment Market, by End-user

  • Hospitals
  • Cancer Centers
  • Others

Global Pituitary Cancer Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Pituitary Cancer Treatment Market

Pre Book